ARTV
Artiva Biotherapeutics
ARTV
ARTV
48 hedge funds and large institutions have $27.9M invested in Artiva Biotherapeutics in 2025 Q2 according to their latest regulatory filings, with 12 funds opening new positions, 9 increasing their positions, 16 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
less funds holding
Funds holding: →
less ownership
Funds ownership: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
44% less repeat investments, than reductions
Existing positions increased: 9 | Existing positions reduced: 16
55% less capital invested
Capital invested by funds: $62.8M → $27.9M (-$34.8M)
Holders
48
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$687K | |
| 2 | +$163K | |
| 3 | +$160K | |
| 4 |
Marshall Wace
London,
United Kingdom
|
+$110K |
| 5 |
Jane Street
New York
|
+$92.9K |
Top Sellers
| 1 | -$2.6M | |
| 2 | -$1.6M | |
| 3 | -$1.31M | |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
-$528K |
| 5 |
LGM
Logos Global Management
San Francisco,
California
|
-$435K |